Tag: managed care industry

Labs Should Build Payer Relationships to Improve Commodity Pricing

“Health plans are interested in improving outcomes and saving money on complex, expensive cases because that’s where the money is. At the same time, that’s an opportunity for labs to help health plans cut costs while also improving quality. ”
—Kerry Kaplan, President, Healthcare Solutions
CEO Summary: At the most recent Executive War College, Kerry Kaplan, President

View Article

LabCorp Exec Discusses Reasons Behind Its 10-Year Pact with United

“This 10-year agreement is unique in the laboratory industry. It speaks to the long-term commitment of both parties.”—Brad Smith, Executive Vice President, Laboratory Corporation of America
CEO SUMMARY: It was unprecedented when UnitedHealth Group announced an exclusive, 10-year laboratory testing services agreement with Laboratory Corporation of America Holdings. This is a high-stakes development for both companies.

View Article

New Lab Test Technology Must Meet Five Payer Requirements

HOSPITALS ARE NOT THE ONLY healthcare player wary of the high cost of new diagnostic test technologies. Insurance companies all over the United States have increased their scrutiny of new medical technology, including laboratory tests.

In a visit to Wall Street last week, THE DARK REPORT attended Bank of America Securities’ conference on “Genomics & Diagnostics:

View Article

Pacificare, IBM, Keane, MedicaLogic/MedScape, WebMD, DrKoop.com

PACIFICARE BEGINS SERIOUS RESTRUCTURING TO SHIFT EMPHASIS
NOT SO MANY YEARS AGO, PacifiCare Health Systems Inc. was considered the quintessential embodiment of all that was expected to be good with managed healthcare.

The company’s business model was studied and copied in cities throughout the country. It shifted 100% of the risk on providers, used capitation almost exclusively,

View Article

“December 17, 2001 Intelligence: Late Breaking Lab News”

Laboratorians interested in the economic paradoxes that sunk the managed care industry might be interested in a new book, Oxymorons: The Myth of a U.S. Healthcare System. Author J.D. Kleinke provides a lucid analysis of the contradictions in our healthcare system. For example, Kleinke describes how incentives could lead money-minded HMOs to decide not to

View Article

2001’s Ten Big Stories Presage Future Direction

CEO SUMMARY: During 2001, few labs found themselves under intense pressure to change or react to dramatic events in the healthcare marketplace. Like 2000, this past year was marked by evolutionary progress, not revolutionary change. However, continuing signs indicate that consumers will play a greater role in decisions involving lab tests. One surprise: slow growth

View Article